Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Liver Neoplasms × Polyethylene Glycols × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 2 Uveal Melanoma 1 Polyps 1 Ovarian Neoplasms 1 Neoplasms 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Liver Neoplasms 1 Leukemia, Myeloid, Acute 1

Interventions

Sorafenib 20 Bevacizumab 13 pembrolizumab 9 durvalumab 7 Ipilimumab 6 Talaporfin 5 Nivolumab 5 Drug Therapy 5 spartalizumab 4 lenvatinib 4 atezolizumab 4 regorafenib 3 derazantinib 3 Ramucirumab 3 Photochemotherapy 3 Leucovorin 3 Injections 3 Fluorouracil 3 Doxorubicin 3 tremelimumab 2 toripalimab 2 seocalcitol 2 phosphomannopentaose sulfate 2 liposomal doxorubicin 2 exatecan 2 brivanib 2 Phototherapy 2 Oxaliplatin 2 Oncolytic Virotherapy 2 Irinotecan 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02006030 2018-09-04

TACE

Polaris Group

Phase 2 Completed

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡